<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Oppenheimer Holdings, Inc. — News on 6ix</title>
<link>https://6ix.com/company/oppenheimer-holdings-inc</link>
<description>Latest news and press releases for Oppenheimer Holdings, Inc. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Fri, 01 May 2026 12:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/oppenheimer-holdings-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835a70a78dffbe2df10bc45.webp</url>
<title>Oppenheimer Holdings, Inc.</title>
<link>https://6ix.com/company/oppenheimer-holdings-inc</link>
</image>
<item>
<title>Oppenheimer Holdings Inc. Reports First Quarter 2026 Earnings</title>
<link>https://6ix.com/company/oppenheimer-holdings-inc/news/oppenheimer-holdings-inc-reports-first-quarter-2026-earnings</link>
<guid isPermaLink="true">https://6ix.com/company/oppenheimer-holdings-inc/news/oppenheimer-holdings-inc-reports-first-quarter-2026-earnings</guid>
<pubDate>Fri, 01 May 2026 12:00:00 GMT</pubDate>
<description>Oppenheimer Holdings Inc. (NYSE: OPY) (the "Company" or "Firm") today reported a net loss of $20.6 million or $(1.93) per share (basic and diluted) for the first quarter of 2026, compared with net income of $30.7 million or $2.93 basic earnings per share for the first quarter of 2025. Revenue for the first quarter of 2026 was $445.1 million, an increase of 21.0%, compared to revenue of $367.8 million for the first quarter of 2025.</description>
</item>
<item>
<title>OPPENHEIMER HOLDINGS INC. Settles "Cash Sweep" Litigation</title>
<link>https://6ix.com/company/oppenheimer-holdings-inc/news/oppenheimer-holdings-inc-settles-cash-sweep-litigation</link>
<guid isPermaLink="true">https://6ix.com/company/oppenheimer-holdings-inc/news/oppenheimer-holdings-inc-settles-cash-sweep-litigation</guid>
<pubDate>Fri, 24 Apr 2026 22:36:00 GMT</pubDate>
<description>Oppenheimer Holdings Inc. ("OPY") today announced that its principal operating subsidiary, Oppenheimer & Co. Inc. ("Oppenheimer"), reached an agreement to settle the previously disclosed litigation styled Liberty Capital Group, Individually and on Behalf of All Others Similarly Situated v. Oppenheimer Holdings Inc., Oppenheimer & Co. Inc., and Oppenheimer Asset Management Inc., No. 1:25-cv04822-JSR which was filed in the United States District Court for the Southern District of New York in June</description>
</item>
<item>
<title>Oppenheimer & Co. Inc. Expands Industrials Research Capabilities with Addition of Brent Thielman</title>
<link>https://6ix.com/company/oppenheimer-holdings-inc/news/oppenheimer-and-co-inc-expands-industrials-research-capabilities-with-addition-of-brent-thielman</link>
<guid isPermaLink="true">https://6ix.com/company/oppenheimer-holdings-inc/news/oppenheimer-and-co-inc-expands-industrials-research-capabilities-with-addition-of-brent-thielman</guid>
<pubDate>Wed, 22 Apr 2026 10:00:00 GMT</pubDate>
<description>Oppenheimer & Co. Inc., a leading investment bank and wealth manager and a subsidiary of Oppenheimer Holdings, today announced that Brent Thielman has joined the firm as a Managing Director on its Equities Research team.</description>
</item>
<item>
<title>PHINIA to Participate in Oppenheimer’s 21st Annual Industrial Growth Conference</title>
<link>https://6ix.com/company/oppenheimer-holdings-inc/news/phinia-to-participate-in-oppenheimers-21st-annual-industrial-growth-conference-1</link>
<guid isPermaLink="true">https://6ix.com/company/oppenheimer-holdings-inc/news/phinia-to-participate-in-oppenheimers-21st-annual-industrial-growth-conference-1</guid>
<pubDate>Tue, 21 Apr 2026 11:30:00 GMT</pubDate>
<description>AUBURN HILLS, Mich., April 21, 2026--PHINIA Inc. (NYSE: PHIN), a leader in premium fuel systems, electrical systems and aftermarket solutions, announced today that it will participate in Oppenheimer’s 21st Annual Industrial Growth Conference on Tuesday, May 5, 2026. Conference participation will be virtual and include a Q&A session to discuss dynamics across the various markets PHINIA serves around the world and the Company’s business.</description>
</item>
<item>
<title>Oppenheimer Adds David Fleming to Private Client Division Leadership Team</title>
<link>https://6ix.com/company/oppenheimer-holdings-inc/news/oppenheimer-adds-david-fleming-to-private-client-division-leadership-team</link>
<guid isPermaLink="true">https://6ix.com/company/oppenheimer-holdings-inc/news/oppenheimer-adds-david-fleming-to-private-client-division-leadership-team</guid>
<pubDate>Thu, 09 Apr 2026 10:00:00 GMT</pubDate>
<description>Oppenheimer & Co. Inc., a leading wealth manager and investment bank and a subsidiary of Oppenheimer Holdings Inc. (NYSE: OPY), today announced that David Fleming has been promoted to a leadership role within the firm's Private Client Division. He will be based in New York.</description>
</item>
<item>
<title>Oppenheimer Names Bill Farmer Managing Director, Head of Aerospace & Defense Technology Investment Banking</title>
<link>https://6ix.com/company/oppenheimer-holdings-inc/news/oppenheimer-names-bill-farmer-managing-director-head-of-aerospace-and-defense-technology-investment-banking</link>
<guid isPermaLink="true">https://6ix.com/company/oppenheimer-holdings-inc/news/oppenheimer-names-bill-farmer-managing-director-head-of-aerospace-and-defense-technology-investment-banking</guid>
<pubDate>Wed, 08 Apr 2026 10:00:00 GMT</pubDate>
<description>Oppenheimer & Co. Inc. (Oppenheimer), a leading investment bank, wealth manager, and subsidiary of Oppenheimer Holdings Inc. (NYSE: OPY), today announced that Bill Farmer has joined the firm as Managing Director and Head of Aerospace & Defense Technology Investment Banking.</description>
</item>
<item>
<title>Oppenheimer Expands Municipal Capital Markets Platform with Three Managing Director Hires</title>
<link>https://6ix.com/company/oppenheimer-holdings-inc/news/oppenheimer-expands-municipal-capital-markets-platform-with-three-managing-director-hires</link>
<guid isPermaLink="true">https://6ix.com/company/oppenheimer-holdings-inc/news/oppenheimer-expands-municipal-capital-markets-platform-with-three-managing-director-hires</guid>
<pubDate>Tue, 31 Mar 2026 13:00:00 GMT</pubDate>
<description>Oppenheimer & Co. Inc. (Oppenheimer), a leading investment bank, wealth manager, and subsidiary of Oppenheimer Holdings Inc. (NYSE: OPY), today announced the hiring of three Managing Directors: Matt Davis, Head of Competitive Municipal Underwriting; Lauren Carter, Competitive Municipal Underwriting; and Brendan Shanahan, Municipal Trading.</description>
</item>
<item>
<title>Oppenheimer Appoints Chris DeFalco And John Hyland As Co-Heads Of Equity Capital Markets</title>
<link>https://6ix.com/company/oppenheimer-holdings-inc/news/oppenheimer-appoints-chris-defalco-and-john-hyland-as-co-heads-of-equity-capital-markets</link>
<guid isPermaLink="true">https://6ix.com/company/oppenheimer-holdings-inc/news/oppenheimer-appoints-chris-defalco-and-john-hyland-as-co-heads-of-equity-capital-markets</guid>
<pubDate>Tue, 24 Mar 2026 10:00:00 GMT</pubDate>
<description>Oppenheimer & Co. Inc. (Oppenheimer), a leading investment bank, wealth manager, and subsidiary of Oppenheimer Holdings Inc., today announced that Managing Directors Chris DeFalco and John Hyland have been named Co-Heads of the firm's Equity Capital Markets Investment Banking group.</description>
</item>
<item>
<title>Oppenheimer Names Eric Nortman Head of Debt Private Placements</title>
<link>https://6ix.com/company/oppenheimer-holdings-inc/news/oppenheimer-names-eric-nortman-head-of-debt-private-placements</link>
<guid isPermaLink="true">https://6ix.com/company/oppenheimer-holdings-inc/news/oppenheimer-names-eric-nortman-head-of-debt-private-placements</guid>
<pubDate>Tue, 17 Mar 2026 10:00:00 GMT</pubDate>
<description>Oppenheimer & Co. Inc. – a leading investment bank, wealth manager and a subsidiary of Oppenheimer Holdings Inc. (NYSE: OPY) – today announced that Eric Nortman has joined the firm as Managing Director, Head of Debt Private Placements.</description>
</item>
<item>
<title>EDAP to Present at Oppenheimer 36th Annual Healthcare MedTech & Services Conference</title>
<link>https://6ix.com/company/oppenheimer-holdings-inc/news/edap-to-present-at-oppenheimer-36th-annual-healthcare-medtech-and-services-conference-3</link>
<guid isPermaLink="true">https://6ix.com/company/oppenheimer-holdings-inc/news/edap-to-present-at-oppenheimer-36th-annual-healthcare-medtech-and-services-conference-3</guid>
<pubDate>Tue, 10 Mar 2026 11:30:00 GMT</pubDate>
<description>EDAP to Present at Oppenheimer 36th Annual Healthcare MedTech & Services Conference Company to Present and Host 1x1 Investor Meetings on Wednesday, March 18th, 2026 AUSTIN, Texas, March 10, 2026 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to present and, together with Ken Mobeck, Chief Financial Officer, will host 1x1 investor meetings at the upcoming Oppenheimer 36th A</description>
</item>
<item>
<title>Oppenheimer Appoints Vien Le As Managing Director</title>
<link>https://6ix.com/company/oppenheimer-holdings-inc/news/oppenheimer-appoints-vien-le-as-managing-director</link>
<guid isPermaLink="true">https://6ix.com/company/oppenheimer-holdings-inc/news/oppenheimer-appoints-vien-le-as-managing-director</guid>
<pubDate>Wed, 25 Feb 2026 11:00:00 GMT</pubDate>
<description>Oppenheimer & Co. Inc. (Oppenheimer), a leading investment bank, wealth manager and a subsidiary of Oppenheimer Holdings Inc. (NYSE: OPY), today announced it has hired Vien Le as Managing Director in the firm's Public Finance Investment Banking Group. Le will be based in Oppenheimer's Los Angeles office and will report to Beth Coolidge, Managing Director and Head of Public Finance.</description>
</item>
<item>
<title>Actuate Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference</title>
<link>https://6ix.com/company/oppenheimer-holdings-inc/news/actuate-therapeutics-to-present-at-the-oppenheimer-36th-annual-healthcare-life-sciences-conference-1</link>
<guid isPermaLink="true">https://6ix.com/company/oppenheimer-holdings-inc/news/actuate-therapeutics-to-present-at-the-oppenheimer-36th-annual-healthcare-life-sciences-conference-1</guid>
<pubDate>Tue, 24 Feb 2026 13:45:00 GMT</pubDate>
<description>CHICAGO and FORT WORTH, Texas, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers through the inhibition of glycogen synthase kinase-3 beta (GSK-3β), today announced that Dan Schmitt, President & CEO of the Company, will present at the Oppenheimer 36th Annual Healthcare Life Sciences conference on February 2</description>
</item>
<item>
<title>Pelthos Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference</title>
<link>https://6ix.com/company/oppenheimer-holdings-inc/news/pelthos-therapeutics-to-present-at-the-oppenheimer-36th-annual-healthcare-life-sciences-conference-1</link>
<guid isPermaLink="true">https://6ix.com/company/oppenheimer-holdings-inc/news/pelthos-therapeutics-to-present-at-the-oppenheimer-36th-annual-healthcare-life-sciences-conference-1</guid>
<pubDate>Mon, 23 Feb 2026 13:00:00 GMT</pubDate>
<description>DURHAM, N.C., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs (“Pelthos”), today announced that its CEO, Scott Plesha, will present at the Oppenheimer 36th Annual Healthcare Life Sciences conference on February 26, 2026 at 10:00 a.m. Eastern Time. The Pelthos management team is scheduled to host one-on-one meetings with investors and attendees during</description>
</item>
<item>
<title>NodThera to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference</title>
<link>https://6ix.com/company/oppenheimer-holdings-inc/news/nodthera-to-present-at-oppenheimer-36th-annual-healthcare-life-sciences-conference</link>
<guid isPermaLink="true">https://6ix.com/company/oppenheimer-holdings-inc/news/nodthera-to-present-at-oppenheimer-36th-annual-healthcare-life-sciences-conference</guid>
<pubDate>Mon, 23 Feb 2026 13:00:00 GMT</pubDate>
<description>BOSTON, Feb. 23, 2026 (GLOBE NEWSWIRE) -- NodThera, the leading clinical-stage NLRP3 company developing a portfolio of best-in-class brain-penetrant and immune-targeted oral inhibitors to address cardiometabolic and neuroinflammatory diseases driven by the NLRP3/IL-6/IL-1 inflammation pathway, today announced that Geoff McDonough, M.D., Chief Executive Officer of NodThera, will present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference being held February 25-26, 2026, in a virtua</description>
</item>
<item>
<title>Vaxart to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 25, 2026</title>
<link>https://6ix.com/company/oppenheimer-holdings-inc/news/vaxart-to-present-at-the-oppenheimer-36th-annual-healthcare-life-sciences-conference-on-february-25-2026</link>
<guid isPermaLink="true">https://6ix.com/company/oppenheimer-holdings-inc/news/vaxart-to-present-at-the-oppenheimer-36th-annual-healthcare-life-sciences-conference-on-february-25-2026</guid>
<pubDate>Wed, 18 Feb 2026 13:00:00 GMT</pubDate>
<description>SOUTH SAN FRANCISCO, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a range of oral vaccines based on its proprietary delivery platform, today announced that members of the management team will present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference taking place virtually February 25-26, 2026. Presentation Details: Date and Time: Wednesday, February 25 at 4:00pm ETRegistration and Webcast: Click Here The</description>
</item>
<item>
<title>Ligand to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference</title>
<link>https://6ix.com/company/oppenheimer-holdings-inc/news/ligand-to-present-at-the-oppenheimer-36th-annual-healthcare-life-sciences-conference-2</link>
<guid isPermaLink="true">https://6ix.com/company/oppenheimer-holdings-inc/news/ligand-to-present-at-the-oppenheimer-36th-annual-healthcare-life-sciences-conference-2</guid>
<pubDate>Wed, 04 Feb 2026 12:00:00 GMT</pubDate>
<description>JUPITER, Fla., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd Davis and Chief Financial Officer Tavo Espinoza will participate in a fireside chat at the Oppenheimer 36th Annual Healthcare Life Sciences Conference, which will be held virtually, on February 25, 2026 at 10:00 a.m. Eastern Time. Ligand management is scheduled to host one-on-one meetings with investors and attendees during the conference. Investor</description>
</item>
<item>
<title>Oppenheimer Holdings Inc. Reports Fourth Quarter and Full Year 2025 Earnings</title>
<link>https://6ix.com/company/oppenheimer-holdings-inc/news/oppenheimer-holdings-inc-reports-fourth-130000318</link>
<guid isPermaLink="true">https://6ix.com/company/oppenheimer-holdings-inc/news/oppenheimer-holdings-inc-reports-fourth-130000318</guid>
<pubDate>Fri, 30 Jan 2026 13:00:00 GMT</pubDate>
<description>Oppenheimer Holdings Inc. (NYSE: OPY) (the "Company" or "Firm") today reported net income of $74.4 million or $7.08 basic earnings per share for the fourth quarter of 2025 compared with net income of $10.7 million or $1.04 basic earnings per share for the fourth quarter of 2024, an increase of 593.1%. Revenue for the fourth quarter of 2025 was $472.6 million compared to revenue of $375.4 million for the fourth quarter of 2024, an increase of 25.9%.</description>
</item>
<item>
<title>InTest Corporation to Participate in the Oppenheimer 11th Annual Emerging Growth Conference</title>
<link>https://6ix.com/company/oppenheimer-holdings-inc/news/intest-corporation-to-participate-in-the-oppenheimer-11th-annual-emerging-growth-conference-1</link>
<guid isPermaLink="true">https://6ix.com/company/oppenheimer-holdings-inc/news/intest-corporation-to-participate-in-the-oppenheimer-11th-annual-emerging-growth-conference-1</guid>
<pubDate>Wed, 28 Jan 2026 13:00:00 GMT</pubDate>
<description>MT. LAUREL, N.J., January 28, 2026--InTest Corporation (NYSE American: INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include semiconductor ("semi"), automotive/EV, defense/aerospace, industrial, life sciences, and safety/security, today announced that Nick Grant, President & CEO, and Duncan Gilmour, Chief Financial Officer, will host virtual investor meetings at the Oppenheimer 11th Annual Emerging Gr</description>
</item>
<item>
<title>Aeva to Participate in the Oppenheimer 11th Annual Emerging Growth Conference</title>
<link>https://6ix.com/company/oppenheimer-holdings-inc/news/aeva-to-participate-in-the-oppenheimer-11th-annual-emerging-growth-conference</link>
<guid isPermaLink="true">https://6ix.com/company/oppenheimer-holdings-inc/news/aeva-to-participate-in-the-oppenheimer-11th-annual-emerging-growth-conference</guid>
<pubDate>Wed, 28 Jan 2026 12:00:00 GMT</pubDate>
<description>MOUNTAIN VIEW, Calif., January 28, 2026--Aeva® (Nasdaq: AEVA), a leader in next-generation sensing and perception systems, today announced that Aeva management will participate in the following investor event:</description>
</item>
<item>
<title>NextNav to Participate in the Oppenheimer 11th Annual Emerging Growth Conference</title>
<link>https://6ix.com/company/oppenheimer-holdings-inc/news/nextnav-to-participate-in-the-oppenheimer-11th-annual-emerging-growth-conference</link>
<guid isPermaLink="true">https://6ix.com/company/oppenheimer-holdings-inc/news/nextnav-to-participate-in-the-oppenheimer-11th-annual-emerging-growth-conference</guid>
<pubDate>Thu, 22 Jan 2026 21:15:00 GMT</pubDate>
<description>RESTON, Va., January 22, 2026--NextNav Inc. (Nasdaq: NN), a leader in next-generation terrestrial Positioning, Navigation, and Timing (PNT) and 3D geolocation solutions, today announced that Chief Financial Officer, Tim Gray will participate in the Oppenheimer 11th Annual Emerging Growth Conference, held virtually February 3-4, 2026.</description>
</item>
</channel>
</rss>